Skip to main content
Erschienen in:

13.10.2022 | Original Article

Delayed Diagnosis of Chronic Necrotizing Granulomatous Skin Lesions due to TAP2 Deficiency

verfasst von: Ilad Alavi Darazam, Atousa Hakamifard, Mana Momenilandi, Marie Materna, Farid Javandoust Gharehbagh, Mohammad Shahrooei, Nasrin Alipour Olyaei, Farahnaz Bidari Zerehpoosh, Antoine Fayand, Firouze Hatami, Legha Lotfollahi, Nahal Mansouri, Jean-Laurent Casanova, Vivien Béziat, Davood Mansouri

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Major histocompatibility complex class I (MHC-I) deficiency, also known as bare lymphocyte syndrome type 1 (BLS-1), is a rare autosomal recessively inherited immunodeficiency disorder with remarkable clinical and biological heterogeneity. Transporter associated with antigen processing (TAP) is a member of the ATP-binding cassette superfamily of transporters and consists of two subunits, TAP1 or TAP2. Any defect resulting from a mutation or deletion of these two subunits may adversely affect the peptide translocation in the endoplasmic reticulum, which is an important process for properly assembling MHC-I molecules. To date, only 12 TAP2-deficient patients were reported in the literature. Herein, we described two Iranian cases with 2 and 3 decades of delayed diagnosis of chronic necrotizing granulomatous skin lesions due to TAP2 deficiency without pulmonary involvement. Segregation analysis in family members identified 3 additional homozygous asymptomatic carriers. In both asymptomatic and symptomatic carriers, HLA-I expression was only 4–15% of the one observed in healthy controls. We performed the first deep immunophenotyping in TAP2-deficient patients. While total CD8 T cell counts were normal as previously reported, the patients showed strongly impaired naïve CD8 T cell counts. Mucosal-associated invariant T (MAIT) cells and invariant natural killer T (iNKT) cell counts were increased.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wieczorek M, et al. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol. 2017;8:292.CrossRef Wieczorek M, et al. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol. 2017;8:292.CrossRef
2.
Zurück zum Zitat Grommé M, Neefjes J. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol. 2002;39(3–4):181–202.CrossRef Grommé M, Neefjes J. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol. 2002;39(3–4):181–202.CrossRef
3.
Zurück zum Zitat Hewitt EW. The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology. 2003;110(2):163–9.CrossRef Hewitt EW. The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology. 2003;110(2):163–9.CrossRef
4.
Zurück zum Zitat Watts C, Powis S. Pathways of antigen processing and presentation. Rev Immunogenet. 1999;1(1):60–74. Watts C, Powis S. Pathways of antigen processing and presentation. Rev Immunogenet. 1999;1(1):60–74.
5.
Zurück zum Zitat Ljunggren H-G, Kärre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today. 1990;11:237–44.CrossRef Ljunggren H-G, Kärre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today. 1990;11:237–44.CrossRef
6.
Zurück zum Zitat Gadola SD, et al. TAP deficiency syndrome. Clin Exp Immunol. 2000;121(2):173–8.CrossRef Gadola SD, et al. TAP deficiency syndrome. Clin Exp Immunol. 2000;121(2):173–8.CrossRef
7.
Zurück zum Zitat Zimmer J, et al. Clinical and immunological aspects of HLA class I deficiency. QJM. 2005;98(10):719–27.CrossRef Zimmer J, et al. Clinical and immunological aspects of HLA class I deficiency. QJM. 2005;98(10):719–27.CrossRef
8.
Zurück zum Zitat Touraine J-L, et al. Combined immunodeficiency disease associated with absence of cell-surface HLA-A and-B antigens. J Pediatr. 1978;93(1):47–51.CrossRef Touraine J-L, et al. Combined immunodeficiency disease associated with absence of cell-surface HLA-A and-B antigens. J Pediatr. 1978;93(1):47–51.CrossRef
9.
Zurück zum Zitat Moins-Teisserenc HT, et al. Association of a syndrome resembling Wegener’s granulomatosis with low surface expression of HLA class-I molecules. Lancet. 1999;354(9190):1598–603.CrossRef Moins-Teisserenc HT, et al. Association of a syndrome resembling Wegener’s granulomatosis with low surface expression of HLA class-I molecules. Lancet. 1999;354(9190):1598–603.CrossRef
10.
Zurück zum Zitat de la Salle H, et al. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest. 1999;103(5):R9–13.CrossRef de la Salle H, et al. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest. 1999;103(5):R9–13.CrossRef
11.
Zurück zum Zitat Ardeniz Ö, et al. β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system. J Allergy Clin Immunol. 2015;136(2):392–401.CrossRef Ardeniz Ö, et al. β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system. J Allergy Clin Immunol. 2015;136(2):392–401.CrossRef
12.
Zurück zum Zitat Béziat V, et al. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE. 2010;5(8):e11966.CrossRef Béziat V, et al. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE. 2010;5(8):e11966.CrossRef
13.
Zurück zum Zitat Béziat V, et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood. 2013;121(14):2678–88.CrossRef Béziat V, et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood. 2013;121(14):2678–88.CrossRef
14.
Zurück zum Zitat Béziat V, et al. Polyclonal expansion of NKG2C+ NK cells in TAP-deficient patients. Front Immunol. 2015;6:507.CrossRef Béziat V, et al. Polyclonal expansion of NKG2C+ NK cells in TAP-deficient patients. Front Immunol. 2015;6:507.CrossRef
15.
Zurück zum Zitat España A, et al. A novel mutation in the TAP2 gene in bare lymphocyte syndrome: association with metastatic cutaneous squamous cell carcinoma. Arch Dermatol. 2010;146(1):96–8.CrossRef España A, et al. A novel mutation in the TAP2 gene in bare lymphocyte syndrome: association with metastatic cutaneous squamous cell carcinoma. Arch Dermatol. 2010;146(1):96–8.CrossRef
16.
Zurück zum Zitat Konstantinou P, et al. Transporter associated with antigen processing deficiency syndrome: case report of an adolescent with chronic perforated granulomatous skin lesions due to TAP 2 mutation. Pediatr Dermatol. 2013;30(6):e223–5.CrossRef Konstantinou P, et al. Transporter associated with antigen processing deficiency syndrome: case report of an adolescent with chronic perforated granulomatous skin lesions due to TAP 2 mutation. Pediatr Dermatol. 2013;30(6):e223–5.CrossRef
17.
Zurück zum Zitat de la Salle H, et al. Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP). Clin Exp Immunol. 2002;128(3):525–31.CrossRef de la Salle H, et al. Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP). Clin Exp Immunol. 2002;128(3):525–31.CrossRef
18.
Zurück zum Zitat Crespı́ C, et al. Skewed inhibitory receptors expression in a TAP2-deficient patient. Immunology letters. 2003;86(2):149–53.CrossRef Crespı́ C, et al. Skewed inhibitory receptors expression in a TAP2-deficient patient. Immunology letters. 2003;86(2):149–53.CrossRef
19.
Zurück zum Zitat de La Salle H, et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science. 1994;265(5169):237–41.CrossRef de La Salle H, et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science. 1994;265(5169):237–41.CrossRef
20.
Zurück zum Zitat Donato L, et al. Déficit en antigènes HLA de classe I et bronchectasies familiales: revue de la littérature avec étude clinique et biologique. Revue française d’allergologie et d’immunologie clinique. 1997;37(2):127–34.CrossRef Donato L, et al. Déficit en antigènes HLA de classe I et bronchectasies familiales: revue de la littérature avec étude clinique et biologique. Revue française d’allergologie et d’immunologie clinique. 1997;37(2):127–34.CrossRef
21.
Zurück zum Zitat Donato L, et al. Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis. J Pediatr. 1995;127(6):895–900.CrossRef Donato L, et al. Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis. J Pediatr. 1995;127(6):895–900.CrossRef
22.
Zurück zum Zitat Markel G, et al. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood. 2004;103(5):1770–8.CrossRef Markel G, et al. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood. 2004;103(5):1770–8.CrossRef
23.
Zurück zum Zitat Matamoros N, et al. Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency. Clin Exp Immunol. 2001;125(2):274–82.CrossRef Matamoros N, et al. Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency. Clin Exp Immunol. 2001;125(2):274–82.CrossRef
24.
Zurück zum Zitat Teisserenc H, et al. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. Immunol Lett. 1997;57(1–3):183–7.CrossRef Teisserenc H, et al. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. Immunol Lett. 1997;57(1–3):183–7.CrossRef
25.
Zurück zum Zitat Shrestha D, Szöllősi J, Jenei A. Bare lymphocyte syndrome: an opportunity to discover our immune system. Immunol Lett. 2012;141(2):147–57.CrossRef Shrestha D, Szöllősi J, Jenei A. Bare lymphocyte syndrome: an opportunity to discover our immune system. Immunol Lett. 2012;141(2):147–57.CrossRef
26.
Zurück zum Zitat Saleem M, et al. Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child. 2000;83(4):356–9.CrossRef Saleem M, et al. Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child. 2000;83(4):356–9.CrossRef
27.
Zurück zum Zitat Villa-Forte A, et al. HLA class I deficiency syndrome mimicking Wegener’s granulomatosis. Arthritis Rheum. 2008;58(8):2579–82.CrossRef Villa-Forte A, et al. HLA class I deficiency syndrome mimicking Wegener’s granulomatosis. Arthritis Rheum. 2008;58(8):2579–82.CrossRef
28.
Zurück zum Zitat Tsilifis C, et al. Stem cell transplantation as treatment for major histocompatibility class I deficiency. Clin Immunol. 2021;229:108801.CrossRef Tsilifis C, et al. Stem cell transplantation as treatment for major histocompatibility class I deficiency. Clin Immunol. 2021;229:108801.CrossRef
29.
Zurück zum Zitat Beckman EM, et al. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature. 1994;372(6507):691–4.CrossRef Beckman EM, et al. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature. 1994;372(6507):691–4.CrossRef
30.
Zurück zum Zitat Karamooz E, Harriff MJ, Lewinsohn DM. MR1-dependent antigen presentation. Semin Cell Dev Biol. 2018;84:58–64.CrossRef Karamooz E, Harriff MJ, Lewinsohn DM. MR1-dependent antigen presentation. Semin Cell Dev Biol. 2018;84:58–64.CrossRef
31.
Zurück zum Zitat Kjer-Nielsen L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491(7426):717–23.CrossRef Kjer-Nielsen L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491(7426):717–23.CrossRef
32.
Zurück zum Zitat Wani MA, et al. Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant β2-microglobulin gene. Proc Natl Acad Sci. 2006;103(13):5084–9.CrossRef Wani MA, et al. Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant β2-microglobulin gene. Proc Natl Acad Sci. 2006;103(13):5084–9.CrossRef
Metadaten
Titel
Delayed Diagnosis of Chronic Necrotizing Granulomatous Skin Lesions due to TAP2 Deficiency
verfasst von
Ilad Alavi Darazam
Atousa Hakamifard
Mana Momenilandi
Marie Materna
Farid Javandoust Gharehbagh
Mohammad Shahrooei
Nasrin Alipour Olyaei
Farahnaz Bidari Zerehpoosh
Antoine Fayand
Firouze Hatami
Legha Lotfollahi
Nahal Mansouri
Jean-Laurent Casanova
Vivien Béziat
Davood Mansouri
Publikationsdatum
13.10.2022
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2023
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-022-01374-7

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Koronare Herzkrankheit: Das waren die Top-Studien 2024

Zum Thema Koronare Herzkrankheit gab es 2024 wichtige neue Studien. Beleuchtet wurden darin unter anderem der Stellenwert von Betablockern nach Herzinfarkt, neue Optionen für eine Lipidsenkung sowie die Therapie bei infarktbedingtem kardiogenem Schock.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.